Patents by Inventor James M. Brugger

James M. Brugger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140319035
    Abstract: Features for protecting against leaks in a fluid circuit are disclosed. In a first embodiment, a fluid circuit is housed by another fluid circuit that is configured to capture and convey leaks to leak detector. In a second embodiment, a first indicator of a leak is used to trigger confirmation by blood flow reversal and air detection in the blood circuit.
    Type: Application
    Filed: August 15, 2012
    Publication date: October 30, 2014
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, Dennis M. Treu, James M. Brugger, Daniel Joseph Rubery, JR.
  • Publication number: 20140238909
    Abstract: A method and device for blood treatments that use fluids such as dialysate and replacement fluid for renal replacement therapy. In an embodiment, fluid is passed either by pump or passively by gravity feed, through a microporous sterilization filter from a fluid source to a replacement fluid container. The latter forms a batch that may be used during treatment. The advantage of forming the batch before treatment is that the rate of filtering needn't match the rate of consumption during treatment. As a result, the sterilization filter can have a small capacity. In another embodiment, a filter is placed immediately prior to the point at which the sterile fluid is consumed by the treatment process. The latter may be used in combination with the former embodiment as a last-chance guarantee of sterility and/or that the fluid is free of air bubbles. It may also be used as the primary means of sterile-filtration.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 28, 2014
    Applicant: NxStage Medical, Inc.
    Inventors: James M. BRUGGER, Jeffrey H. BURBANK, Brian C. GREEN
  • Publication number: 20140191501
    Abstract: The disclosed subject matter includes embodiments of fluid couplings that prevent or discourage misconnection of fluid lines. A coupling device includes multiple male and female connectors that are joined to a common line. The coupling device is mated to a matching coupling device only when all the multiple male and female connectors are property joined. If any of the connectors is not property mated to a corresponding one, the coupling will leak. The coupling devices are made unique by providing an arrangement the connectors, number of connectors, shape of connectors or arrangement of interfering connector parts that ensure that any attempt to improperly couple two fluid lines will result in the incomplete mating of one or more of the connectors and thereby cause leakage of the fluid, failure of the coupling to engage, or otherwise cause the attempt to connect to fail.
    Type: Application
    Filed: June 8, 2012
    Publication date: July 10, 2014
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: James M. Brugger, Dennis M. Treu, David S. Utterberg
  • Publication number: 20140076058
    Abstract: A pressure measurement system for use in blood circuits comprised of a pressure sensing pod and a force measurement device. The pressure sensing pod can include a flexible, moveable, fluid-impermeable diaphragm and can be formed via either a one-shot or a two-shot molding process. A mechanical engagement member of the force measurement device engages with a mechanical engagement feature of the diaphragm, and the engagement member is operative to move in concert with movement of the engagement feature of the diaphragm based on pressure variations with the pressure sensing pod. The force measurement device generates and outputs to a processor a signal based on detected force associated with movement of the engagement member.
    Type: Application
    Filed: May 31, 2012
    Publication date: March 20, 2014
    Applicant: NxStage Medical, Inc.
    Inventors: James M. Brugger, Dennis M. Treu, Jeffrey H. Burbank, Scott W. Newell, William J. Schnell, Kenneth E. Buckler
  • Publication number: 20140035273
    Abstract: A restraining device for a tubing connector assembly can include a resilient member having a generally U-shape with forked ends that curve toward each other. Each forked end can have a recess between tines thereof. Each recess can have a blind end. The resilient member can have a bend provided with an engagement bump. The engagement bump and forked ends can be aligned such that the engagement bump coincides with a line joining the blind ends. When a cylindrical connector assembly tube is placed in the recesses, the engagement bump is urged against a side of the connector assembly to thereby prevent inadvertent disconnection.
    Type: Application
    Filed: October 14, 2013
    Publication date: February 6, 2014
    Applicant: NxStage Medical, Inc.
    Inventors: William J. SCHNELL, James M. BRUGGER
  • Patent number: 8641615
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: February 4, 2014
    Assignee: NXstage Medical, Inc.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Publication number: 20140018727
    Abstract: An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals. Other features and embodiments are disclosed.
    Type: Application
    Filed: March 23, 2012
    Publication date: January 16, 2014
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, James M. Brugger, Dennis M. Treu, Mark T. Wyeth
  • Patent number: 8608658
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: December 17, 2013
    Assignee: NxStage Medical, Inc.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Patent number: 8585096
    Abstract: A restraining device for a tubing connector assembly can include a resilient member having a generally U-shape with forked ends that curve toward each other. Each forked end can have a recess between tines thereof. Each recess can have a blind end. The resilient member can have a bend provided with an engagement bump. The engagement bump and forked ends can be aligned such that the engagement bump coincides with a line joining the blind ends. When a cylindrical connector assembly tube is placed in the recesses, the engagement bump is urged against a side of the connector assembly to thereby prevent inadvertent disconnection.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: November 19, 2013
    Assignee: NxStage Medical, Inc.
    Inventors: William J. Schnell, James M. Brugger
  • Publication number: 20130304025
    Abstract: A bandage can be used to secure a needle to an access site so as to prevent unintended movement or withdrawal of the needle from the access site during administration of a treatment to a patient. After treatment, the needle can be removed by manipulating a portion of the bandage. Another portion of the bandage can be maintained in position over the access site during needle removal and can be used to promote clotting of the site after needle removal. The bandage may include a clotting agent, a hemostasis pad, and/or a clot-promoting structure. Additionally or alternatively, finger pressure can be applied to the access site through the bandage. For example, the bandage may include a viewing window without any adhesive to allow visual monitoring of the access site during treatment. Finger pressure may be applied to the viewing window and thereby to the access site during and after needle removal to encourage hemostasis.
    Type: Application
    Filed: July 10, 2013
    Publication date: November 14, 2013
    Inventors: James M. Brugger, Steven C. Alford, William Schnell, Mark Florence
  • Publication number: 20130283891
    Abstract: A flow reversing device for performing blood treatment can include a flow reversing actuator. The flow reversing actuator can receive and engage a disposable tubing set with multiple branches that form forward and reverse blood flow paths respectively when blood the flow reversing actuator is selectively changed between forward and reverse configurations. The shape of the tubing can be such that during forward operation, dead regions of non-flowing blood are defined. The flow reversing actuator can have a controller configured to operate generally in forward mode. At first times, the controller can cause the flow reversing actuator to clear the dead regions. At second times, the controller can cause the flow reversing actuator to test for leaks by reversing the flow of blood for a period of time sufficient to cause air to be drawn into the tubing set and conveyed to an air sensor.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Inventors: JAMES M. BRUGGER, CHRISTOPHER MCDOWELL
  • Publication number: 20130281799
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Application
    Filed: June 18, 2013
    Publication date: October 24, 2013
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Publication number: 20130264250
    Abstract: A first connector of a connector assembly of a sterile batch container can be unsealed. The connector assembly can be attached to a filling port of the sterile batch container and can have a sterile filter arranged between the filling port and the first connector. The first connector can be coupled so as to receive produced purified water. A transmembrane pressure can be monitored across the sterile filter while flowing the purified water through the connector assembly into the sterile batch container so as to provide a sterile fluid stored therein. The connector assembly can be detached from the filling port of the sterile batch container. After the detaching, the sterile batch container can be coupled to the blood treatment system. In response to a change in the transmembrane pressure exceeding a predefined level, an alarm signal can be generated.
    Type: Application
    Filed: June 4, 2013
    Publication date: October 10, 2013
    Inventors: James M. BRUGGER, Jeffrey H. BURBANK, Brian C. GREEN
  • Publication number: 20130228505
    Abstract: Systems, methods, and devices for preparation of purified water and medicaments for various uses including blood treatment are described. Methods, devices, and systems for creating multiple-treatment batches are described. For example, a medicament fluid circuit can include a container with an interior chamber. The container can have a fluid filling port and a fluid extraction port. Both ports can be connected to the interior chamber. The filling port can have two sterilizing filters, each of which has a membrane. The sterilizing filters can be connected in series the membranes are separated by a distance of at least 0.5 cm. A first of the sterilizing filters can have a sealed inlet. The fluid extraction port can be sealed.
    Type: Application
    Filed: April 11, 2013
    Publication date: September 5, 2013
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Patent number: 8496625
    Abstract: A bandage can be used to secure a needle to an access site so as to prevent unintended movement or withdrawal of the needle from the access site during administration of a treatment to a patient. After treatment, the needle can be removed by manipulating a portion of the bandage. Another portion of the bandage can be maintained in position over the access site during needle removal and can be used to promote clotting of the site after needle removal. The bandage may include a clotting agent, a hemostasis pad, and/or a clot-promoting structure. Additionally or alternatively, finger pressure can be applied to the access site through the bandage. For example, the bandage may include a viewing window without any adhesive to allow visual monitoring of the access site during treatment. Finger pressure may be applied to the viewing window and thereby to the access site during and after needle removal to encourage hemostasis.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: July 30, 2013
    Assignee: NxStage Medical, Inc.
    Inventors: James M. Brugger, Steven C. Alford, William Schnell, Mark Florence
  • Publication number: 20130180339
    Abstract: A pressure measuring device has tubing with an inline “pillow” portion that is more flexible than the tubing portion. The pillow portion may be created by heating a portion of a length of medical tubing and forcing air into the heated portion to expand, and thin, its walls. The tubing and pillow portion may be used in a negatively pressurized portion of a blood circuit such as an arterial return line. An assembly of interleaved support members adhesively bonded to the pillow portion holds the pillow portion in an expanded state even under negative pressure. Further, when the pillow portion tries to collapse, the interleaved support members compress a strain gauge to provide a pressure signal corresponding to the negative pressure exerted by the fluid therewithin.
    Type: Application
    Filed: September 23, 2011
    Publication date: July 18, 2013
    Applicant: NxStage Medical, Inc.
    Inventor: James M. Brugger
  • Patent number: 8480608
    Abstract: A blood processing system includes a flow reversing device with at least an air sensor in the venous line located near the patient. During treatment, blood flow is reversed to cause air to infiltrate the blood lines if any disconnections or breaks in the blood line are present. One means for placing the sensor close to the patient is to provide the flow switching device aid sensors in a small lightweight module that can be located close to the treatment machine. Another is to provide a module with just the sensors near the access.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: July 9, 2013
    Assignee: Nxstage Medical, Inc.
    Inventors: James M. Brugger, Christopher McDowell
  • Patent number: 8469331
    Abstract: Systems, methods, and devices for preparation of purified water and medicaments for various uses including blood treatment are described. Methods, devices, and systems for creating multiple-treatment batches are described.
    Type: Grant
    Filed: April 9, 2007
    Date of Patent: June 25, 2013
    Assignee: NxStage Medical, Inc.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Patent number: 8460558
    Abstract: A first connector of a connector assembly of a sterile batch container can be unsealed. The connector assembly can be attached to a filling port of the sterile batch container and can have a sterile filter arranged between the filling port and the first connector. The first connector can be coupled so as to receive produced purified water. A transmembrane pressure can be monitored across the sterile filter while flowing the purified water through the connector assembly into the sterile batch container so as to provide a sterile fluid stored therein. The connector assembly can be detached from the filling port of the sterile batch container. After the detaching, the sterile batch container can be coupled to the blood treatment system. In response to a change in the transmembrane pressure exceeding a predefined level, an alarm signal can be generated.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: June 11, 2013
    Assignee: Nxstage Medical, Inc.
    Inventors: James M. Brugger, Jeffrey H. Burbank, Brian C. Green
  • Patent number: 8460228
    Abstract: A tubing set is disclosed including a first line having first and second ends, a bag spike at the first end configured for connection to a source of infusate, and a connector at the second end configured for connection to a blood line. The first line has a pumping portion for engagement with an infusate pump. The tubing set includes a second line having first and second ends, the first end being attached to the first line between the first line pumping portion and the first line second end and the second end being configured for connection to the first line between the first line first end and the first line pumping portion. The second line second end is configured for connection to the first line by a dual lumen spike.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: June 11, 2013
    Assignee: NxStage Medical Inc.
    Inventors: Jeffrey H. Burbank, Joseph Turk, Dennis M. Treu, R. Michael Hofmann, James M. Brugger